Open access in silico tools to predict the ADMET profiling of drug candidates

Supratik Kar,Jerzy Leszczynski
DOI: https://doi.org/10.1080/17460441.2020.1798926
2020-07-31
Expert Opinion on Drug Discovery
Abstract:We are in an era of bioinformatics and cheminformatics where we can predict data in the fields of medicine, the environment, engineering and public health. Approaches with open access <i>in silico</i> tools have revolutionized disease management due to early prediction of the absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiles of the chemically designed and eco-friendly next-generation drugs.This review meticulously encompasses the fundamental functions of open access <i>in silico</i> prediction tools (webservers and standalone software) and advocates their use in drug discovery research for the safety and reliability of any candidate-drug. This review also aims to help support new researchers in the field of drug design.The choice of <i>in silico</i> tools is critically important for drug discovery and the accuracy of ADMET prediction. The accuracy largely depends on the types of dataset, the algorithm used, the quality of the model, the available endpoints for prediction, and user requirement. The key is to use multiple <i>in silico</i> tools for predictions and comparing the results, followed by the identification of the most probable prediction.
pharmacology & pharmacy
What problem does this paper attempt to address?